| 1. |
- Elliott, Perry, et al.
(författare)
-
Development, validation and implementation of biomarker testing in cardiovascular medicine state-of-the-art : Proceedings of the European Society of Cardiology - Cardiovascular Round Table
- 2021
-
Ingår i: Cardiovascular Research. - : Oxford University Press. - 0008-6363 .- 1755-3245. ; 117:5, s. 1248-1256
-
Tidskriftsartikel (refereegranskat)abstract
- Many biomarkers that could be used to assess ejection fraction, heart failure, or myocardial infarction fail to translate into clinical practice because they lack essential performance characteristics or fail to meet regulatory standards for approval. Despite their potential, new technologies have added to the complexities of successful translation into clinical practice. Biomarker discovery and implementation requires a standardised approach that includes: identification of a clinical need; identification of a valid surrogate biomarker; stepwise assay refinement, demonstration of superiority over current standard-of-care; development and understanding of a clinical pathway; and demonstration of real-world performance. Successful biomarkers should improve efficacy or safety of treatment, while being practical at a realistic cost. Everyone involved in cardiovascular healthcare, including researchers, clinicians, and industry partners, are important stakeholders in facilitating the development and implementation of biomarkers. This paper provides suggestions for a development pathway for new biomarkers, discusses regulatory issues and challenges, and suggestions for accelerating the pathway to improve patient outcomes. Real life examples of successful biomarkers-high sensitivity cardiac troponin (hs-cTn), T2* cardiovascular magnetic resonance (CMR) imaging, and echocardiography-are used to illustrate the value of a standardised development pathway in the translation of concepts into routine clinical practice.
|
|
| 2. |
- Oberstedt, Stephan, et al.
(författare)
-
Light charged particle emission in the reaction 251Cf(nth, f)
- 2005
-
Ingår i: Nuclear Physics A. - : Elsevier BV. - 0375-9474 .- 1873-1554. ; 761:3-4, s. 173-189
-
Tidskriftsartikel (refereegranskat)abstract
- High resolution measurements of light charged particles (LCP) emitted in thermal neutron-induced fission of 252Cf ∗ (E=6.2 MeV) have been performed with the recoil mass-separator LOHENGRIN. For this compound nuclear system emission yields of LCPs, their mean kinetic energies and widths have been obtained for 8 isotopes with nuclear charges Z⩾2. For 13 further isotopes the emission yields were estimated on the basis of systematics on their kinetic energy distributions. 34Al and 36Si emission has been observed for the first time in thermal neutron-induced fission.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
- Tovesson, Fredrik, et al.
(författare)
-
Fission fragment properties and the problem of the pulse height defect
- 2002
-
Ingår i: Journal of Nuclear Science and Technology. - 0022-3131 .- 1881-1248. ; Supplement 2, s. 673-676
-
Tidskriftsartikel (refereegranskat)abstract
- The pulse height defect (PHD) has been investigated for three different counting gases commonly used in ionization chambers. The PHD introduces an underestimation of the kinetic energy of a charged particle detected with an ionization chamber. Thus, in some cases it is of crucial importance to correct for this effect, e.g. when studying fission fragment properties. A now method was used, applying a waveform digitizer, to study the PHD. The fission fragment properties from spontaneous fission of 252Cf where determined using different counting gases and different ways of correcting for the PHD were evaluated.
|
|
